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hen Monocytes Come
Too) Close to Our Hearts*
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oseph L. Witztum, MD,‡
hristoph J. Binder, MD, PHD*†‡
ienna, Austria; and La Jolla, California
yocardial infarction (MI) represents the most frequent
ardiovascular event in the western world and is responsible for
large part of cardiovascular deaths. Currently, improved
linical management of acute MI has significantly lowered
mmediate mortality. However, surviving patients are facing
nother major complication, the development of heart failure,
n part as a consequence of inadequate infarct healing.
n Adequate Healing Process Is Critical
his repair process is of crucial importance to promote the
ealing of damaged myocardial tissue by removal of dead
ells, replacement of necrotic areas by connective tissue, and
emodeling of myocardial structure and geometry to ulti-
ately compensate for the loss of cardiomyocytes (1). Several
hases of infarct healing have been described that include an
nitial inflammatory response, followed by the influx of neu-
rophils and monocyte/macrophages, which orchestrate
See page 1629
ound-healing leading to the formation of a cardiac scar
ithin approximately 3 weeks. Although these compensatory
r regulatory mechanisms are beneficial at first, their prolonged
ersistence can be deleterious as well (1). Therefore, as more
atients survive the acute phase of MI and enter the period of
nfarct healing, a better understanding of the mechanisms that
romote “optimal” infarct healing is needed.
ole of Macrophages in Healing
onocyte-derived macrophages are thought to take a cen-
ral role in the regulation of infarct healing. They facilitate
he wound-healing process (2)—by removing necrotic car-
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niversity of California at San Diego, La Jolla, California.iomyocytes and apoptotic neutrophils as well as in the
ecretion of cytokines, chemokines, and proteases. In fact, a
ecent study showed that macrophage depletion with
lodronate-containing liposomes impaired wound-healing
n a murine MI model (3), and injection of activated
acrophages into the ischemic myocardium has been found
o improve myocardial healing and preserve left ventricular
LV) function in mice (4). Thus, a macrophage-mediated
nflammatory response is critical for an adequate tissue
epair. By contrast, if not properly orchestrated, it might
lso have a detrimental effect. Indeed, leukocyte counts in
he blood of MI patients have been shown to predict
utcome (5–7), and patients with monocytosis were found
o display a higher risk of developing LV dilation, resulting
n an impaired ejection fraction (6,7). However, these
tudies do not address the heterogeneous nature of mono-
yte/macrophages and their differences that might explain
heir dual role in myocardial healing.
ivergent Functions of Monocyte Subsets
ecently, the heterogeneity of circulating monocytes has
ecome the focus of attention in many pathological systems.
n the peripheral blood of mice, 2 major monocyte subsets
ave been described and distinguished according to their
xpression of cell surface proteins (8). The so-called “inflam-
atory” monocytes express high levels of Ly-6C (Ly-6Chi),
he monocyte chemoattractant protein (MCP)-1 receptor
CR2, the adhesion molecules L-selectin (CD62L), alpha-M
ntegrin beta 2 (CD11b), and low levels of the fractalkine
eceptor CX3CR1. They migrate to inflamed tissues, princi-
ally in response to the CCR2 ligand MCP-1. The second
ubset of monocytes has been termed “resident” monocytes,
ecause they are typically found in both resting and inflamed
issues. Although their functions still remain unclear, they have
ecently been suggested to play an important homeostatic role
n patrolling healthy tissues through long-range crawling on
he resting endothelium in the steady state. These monocytes
re defined by the high expression of CX3CR1 and alpha-L
ntegrin beta 2 (CD11a) and lack of expression of Ly-6C
Ly-6Clo), CCR2, and CD62L (8).
onocyte Subsets in Infarct Healing
n a preceding study using a coronary ligation model to
nduce MIs in mice, Nahrendorf et al. (9) found that these
monocyte subsets are sequentially recruited into the
nfarcted area in a process that is orchestrated by the
ifferential expression of the chemokines MCP-1 and frac-
alkine, respectively. Thus, MI repair is characterized by a
iphasic response, in which phase I is dominated by
y-6Chi monocytes that exhibit phagocytic, proteolytic, and
nflammatory properties, whereas phase II is dominated by
he anti-inflammatory Ly-6Clo monocytes that express high
evels of vascular endothelial growth factor. Therefore, the 2onocyte subsets were hypothesized to have divergent roles
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Monocytes in Infarct Healing April 13, 2010:1639–41uring the wound-healing process. The Ly-6Chi monocytes
igest damaged tissue, whereas Ly-6Clo monocytes promote
ealing via myofibroblast accumulation, collagen deposi-
ion, and promotion of angiogenesis (Fig. 1).
Importantly, in humans different monocyte subsets have also
een indentified on the basis of the expression of CD14 and
D16 (8). The CD14CD16 monocytes represent the
ajor subset in the peripheral blood and express CCR2 but
nly low levels of CX3CR1, resembling the “inflammatory”
y-6Chi monocytes in mice. They are potent phagocytes and
roduce large amounts of proinflammatory cytokines. In con-
rast, a smaller subset of monocytes is CD14CD16 and
xclusively express CX3CR1, sharing a phenotype similar to
y-6Clo monocytes in mice. Recently, Tsujioka et al. (10)
tudied the dynamics of these monocyte populations in hu-
ans with acute MI and—in analogy to the murine data
reviously discussed—found an initial rise of “inflammatory”
D14CD16 monocytes followed by a sequent mobiliza-
ion of circulating monocytes with the CD14CD16 phe-
otype. In fact, peak levels of the inflammatory subset were
ound to be negatively correlated with myocardial salvage after
days and recovery of LV function after 6 months.
onocytosis Impairs Infarct Healing in Mice
ahrendorf et al. also studied infarct healing in cholesterol-
ed apolipoprotein E knockout (apoE/) mice, which are
nown to have increased levels of circulating Ly-6Chi
onocytes (11). The apoE/ mice were found to have
ncreased signs of impaired infarct healing, suggesting a
entral role for monocytes in the outcome of MI repair.
owever, it was not clear whether this impairment was due
Figure 1 Finding the Right Balance: Distinct Monocyte Subsets
CCR2  chemokine (C-C motif) receptor 2; CX3CR1  chemokine (C-X3-C motif) reo the monocytosis itself, a disturbed transition from phase cto phase II, an altered monocyte function in general, or
ther factors related to the apoE deficiency.
Now, Panizzi et al. (12) shed light on these important
uestions. With their established MI model, the authors
ound 10 higher levels of Ly-6Chi monocytes and a
ignificantly increased ratio of Ly-6Chi/Ly6Clo monocytes
n the infarcted areas of apoE/ mice during phase II (day
after MI), which is usually dominated by Ly-6Clo mono-
ytes. They could further document, consistent with the
ncreased levels of Ly-6Chi monocytes, increased proteolytic
nd phagocytic activity in the infarcted tissues of apoE/
ice compared with nonatherosclerotic mice, despite equal
nfarct size. Consequently, LV remodeling was impaired in
poE/ mice, resulting in an increased end-diastolic vol-
me and significantly worsened ejection fraction. Impor-
antly, with in vivo administered fluorescent probes for
roteolytic and phagocytic activity followed by flow-
ytometric analyses of cells of the digested infarct tissue, the
ajority of the proteolytic activity could be attributed to the
y-6Chi monocytes. The contribution of neutrophils, which
lso possess high proteolytic activity and are equally in-
reased in atherosclerotic mice, could be ruled out by
epletion with a specific antibody, which did not rescue this
henotype. Finally, to demonstrate that the persistent pres-
nce of Ly-6Chi monocytes with proteolytic activity, as
ound in atherosclerotic mice, is indeed responsible for dereg-
lated wound-healing, the authors employed a model of
ipopolysaccaride-induced monocytosis in wild-type mice. In
his model, the isolated increase of Ly-6Chi monocytes in the
lood and the infarcted tissues resulted in an analogous
henotype as seen in apoE/ mice. Thus, the presence of
ncreased numbers of inflammatory monocytes in the infarct
diate Resolution and Repair in Myocardial Infarction
r 1; MCP  monocyte chemoattractant protein; PMN  neutrophils.Me
ceptoould be directly linked to the outcome of LV remodeling.
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April 13, 2010:1639–41 Monocytes in Infarct HealingThese data identify Ly-6Chi monocytes as the culprit cells
or impaired infarct healing, although the exact mechanism for
heir persistence in infarcted areas of atherosclerotic mice
emains to be shown. It is still unclear whether their domi-
ance throughout the healing process simply reflects the
ncreased circulating levels seen in these mice or whether it is
consequence of increased and persistent local expression of
pecific ligands for CCR2, most prominently MCP-1. More-
ver, it is not clear whether the dynamic expression of chemo-
ines that have been shown to be crucial for the recruitment of
oth monocyte subsets and the orchestration of a proper
ealing process is altered in atherosclerotic mice. What are the
actors that control this biphasic chemokine expression during the
ealing process? How is phase I ended? And what initiates phase
I of infarct healing? It might well be that the ongoing chronic
nflammation in atherosclerotic mice generates an environment
hat significantly hampers this transition, irrespective of the high
evels of circulating monocytes. To answer this, a more detailed
nderstanding of the physiological healing processes that occur
fter an MI and the factors modulating it is needed.
Such knowledge will likely offer potential therapeutic
argets to modulate or correct a deregulated wound-healing
rocess. Of interest, statin treatment of atherosclerotic
poE/ mice has been shown to reduce Ly-6Chi monocyte
ounts from peripheral blood and bone marrow (11) and to
own-regulate CCR2 expression of circulating monocytes
n humans (13). Nevertheless, the biphasic response of
roper infarct healing and the necessity for the sequential
ecruitment of both monocyte subsets requires an exact
iming of any given intervention and will likely be the most
hallenging part for translating these findings to humans.
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